Smart Workstation Simplifies Synthesis: METTER TOLEDO’s OptiMax

25 May 2011
bridget bridget
Laboratory Director

Product news

METTLER TOLEDO has introduced OptiMax™, a powerful synthesis workstation optimized for pharmaceutical, fine-chemical and specialty-chemical development. The unique design and intuitive interface improve the organic synthesis process and maximize time-to-result in product development in increasingly competitive markets. The compact workstation requires little to no training to operate and allows experiments to run from -40 to 180°C without oil or ice baths or bulky cryostats.

Rising time-to-market pressure in the chemical and pharmaceutical industries is forcing chemical and process development chemists to turn to more productive tools for organic synthesis and process development. METTLER TOLEDO’s OptiMaxTM can help meet these pressures. The newly designed workstation has been created by chemists for chemists. It simplifies the way organic synthesis is performed and provides significant productivity gains during process development while carefully tracking synthesis to successfully produce quality data.

Chemical and process development chemists are required to make the right decisions faster than ever. Often, this means performing process characterization while optimizing chemistry at the same time. With OptiMaxTM, process development benefits from enhanced traceability and reproducibility.

METTLER TOLEDO’s OptiMax™ provides one simple platform for safe, effective product and process development. “Earlier application testing in specialty chemical research or pharmaceutical pre-clinical trials may be desirable to shorten time-to-market,” said Urs Groth, Marketing Communications Manager Reaction Engineering at METTLER TOLEDO. “Without the right tools, this speed can compromise experiment and data quality or even be dangerous. The challenges—that is, reduced time-to-market, simplification and safety—are overcome with OptiMax™.”

METTLER TOLEDO has made the OptiMax™ synthesis workstation compact, robust and simple to use. The intuitive touch screen allows reaction parameter changes, such as temperature, with just a few clicks. With a variety of reactors from 250 mL to 1 L, different stirrers and other accessories, assembling the workstation or altering configuration is quick and almost effortless.

Ease of execution, accuracy and reproducibility are critical factors in synthesis and development and are ensured by OptiMax™. Experiment data are presented in real time either numerically or as graphic trends. Data recording and reporting capabilities contribute to highly traceable and reproducible results.
Intelligent built-in automation eliminates error-prone steps and reduces process variability. With this high level of automation, OptiMax™ makes nighttime more productive, too. Experiments can be programmed for execution safely around the clock and automatic data logging ensures that no critical process information is missed.

“Essentially, OptiMax™ goes a long way towards eliminating the bottlenecks that often plague high-volume R&D operations,” concluded Groth. “OptiMax™ is a truly useful self-contained walk-up tool that chemists can employ for enhancing synthesis and, thus fast application testing, characterization and optimization of even their most sensitive and high-profile experiments.”

Links

Tags

Combinatorial ChemistryCombinatorial chemistry, also known as combichem, is a technique used in drug discovery to create libraries of structurally related compounds. A library is generated by synthesis with a chemical reactor system or by computer-based modeling of compound combinations. When undertaking combinatorial chemistry consider reagents, buffers, resins and standards.Lab-on-a-ChipLab-on-a-chip (LOC) technology uses microfluidic chips, such as microarrays, to perform biochemical assays on a small scale. Benefits of lab-on-a-chip include the small volume of sample required as well as the speed of analysis. In selecting lab-on-a-chip devices consider the assay, cost, reliability, sensitivity and signal to noise ratio.High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Assay AssemblyAssay Assembly is technique used in drug discovery to develop assays to test the cytotoxicity, genotoxicity, or other activities of a compound on a cell. Assay assembly requires chip assembly, a delivery system and a detection and analysis method. Beneficial features of assay kits or automated systems include high-throughput, high speed and sensitivity and low signal to noise ratio.Compound LibrariesCompound libraries, or chemical libraries, are used in drug discovery for the identification of potential therapeutics compounds. Used in conjunction with high-throughput screening, the libraries of stored compounds are often generated for specific purposes as a drug target or disease model. Cheminformatics are commonly used when designing a compound library and software can be used to analyze the screening process.  Medicinal ChemistryMedicinal chemistry is a broad discipline encompassing the design, identification, synthesis and development of chemicals in drug discovery. It includes a number of techniques covering structural biology, synthetic chemistry and molecular biology. Technologies used in medicinal chemistry include ADME, lab-on-a-chip, high content screening and assay assembly.Microarray AnalysisMicroarrays, also known as biochips, are used for the detection and analysis of multiple genes, proteins, antibodies, or biomarkers on a single microchip. This can reveal information on protein or gene expression, single nucleotide polymorphism (SNP), copy number variation (CNV), epigenetics and patient health in clinical diagnostic tests. Discover a range of microarray scanners and prefabricated antibody, protein, RNA and DNA microarrays for your analysis or consider creating your own custom microarrays with a microarray printer. Find the best microarray products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Process ChemistryProcess chemistry is an important stage of drug development for scaling-up drug production or chemical synthesis reactions. It is useful for optimizing economical and efficient drug production. Process chemistry uses reactors and pump systems as well as reagents, standards and buffers.High-Content ScreeningHigh-content screening (HCS), also known as high-content analysis (HCA), is a high-throughput technique used in drug discovery to identify substances that alter the phenotype of cells. HCS uses fluorescent microscopic imaging and automated image analysis to investigate cellular events such as apoptosis, cell viability, GPCR activation, oxide production, neurite outgrowth, and cell signaling. Find the best fluorescent labeling reagents, cellular assays, and high-content imaging systems in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.